Works by Jong Hee Chang

Results: 177
    1
    2
    3
    4
    5
    6
    7

    Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 2, p. 396, doi. 10.4143/crt.2021.393
    By:
    • Ahn, Grace S.;
    • Kihwan Hwang;
    • Tae Min Kim;
    • Chul Kee Park;
    • Jong Hee Chang;
    • Tae-Young Jung;
    • Jin Hee Kim;
    • Do-Hyun Nam;
    • Se-Hyuk Kim;
    • Heon Yoo;
    • Yong-Kil Hong;
    • Eun-Young Kim;
    • Dong-Eun Lee;
    • Jungnam Joo;
    • Yu Jung Kim;
    • Gheeyoung Choe;
    • Byung Se Choi;
    • Seok-Gu Kang;
    • Jeong Hoon Kim;
    • Chae-Yong Kim
    Publication type:
    Article
    8
    9
    10

    Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).

    Published in:
    Cancer Research & Treatment, 2020, v. 52, n. 2, p. 505, doi. 10.4143/crt.2019.421
    By:
    • Kihwan Hwang;
    • Tae Min Kim;
    • Chul-Kee Park;
    • Jong Hee Chang;
    • Tae-Young Jung;
    • Jin Hee Kim;
    • Do-Hyun Nam;
    • Se-Hyuk Kim;
    • Heon Yoo;
    • Yong-Kil Hong;
    • Eun-Young Kim;
    • Dong-Eun Lee;
    • Jungnam Joo;
    • Yu Jung Kim;
    • Gheeyoung Choe;
    • Byung Se Choi;
    • Seok-Gu Kang;
    • Jeong Hoon Kim;
    • Chae-Yong Kim
    Publication type:
    Article
    11

    Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 1, p. 193, doi. 10.4143/crt.2015.473
    By:
    • Byung Sup Kim;
    • Ho Jun Seo;
    • Do-Hyun Nam;
    • Chul-Kee Park;
    • Il Han Kim;
    • Tae Min Kim;
    • Jeong Hoon Kim;
    • Young Hyun Cho;
    • Sang Min Yoon;
    • Jong Hee Chang;
    • Seok-Gu Kang;
    • Eui Hyun Kim;
    • Chang-Ok Suh;
    • Tae-Young Jung;
    • Kyung-Hwa Lee;
    • Chae-Yong Kim;
    • In Ah Kim;
    • Chang-Ki Hong;
    • Heon Yoo;
    • Jin Hee Kim
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres.

    Published in:
    Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02731-7
    By:
    • Shim, Jin-Kyoung;
    • Choi, Seonah;
    • Yoon, Seon-Jin;
    • Choi, Ran Joo;
    • Park, Junseong;
    • Lee, Eun Hee;
    • Cho, Hye Joung;
    • Lee, Suji;
    • Teo, Wan-Yee;
    • Moon, Ju Hyung;
    • Kim, Hyun Sil;
    • Kim, Eui Hyun;
    • Cheong, Jae-Ho;
    • Chang, Jong Hee;
    • Yook, Jong In;
    • Kang, Seok-Gu
    Publication type:
    Article
    36

    Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection.

    Published in:
    Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02273-2
    By:
    • Li, Xue;
    • Kim, Hyun Jung;
    • Yoo, Jihwan;
    • Lee, Yeonhee;
    • Nam, Chang Hyun;
    • Park, Jonghan;
    • Lee, Soon-Tae;
    • Kim, Tae Min;
    • Choi, Seung Hong;
    • Won, Jae-Kyung;
    • Park, Sung‑Hye;
    • Ju, Young Seok;
    • Park, Jong Bae;
    • Kim, Se Hoon;
    • Chang, Jong Hee;
    • Wu, Hong-Gyun;
    • Park, Chul-Kee;
    • Lee, Jeong Ho;
    • Kang, Seok-Gu;
    • Lee, Joo Ho
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axis.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 10, p. 1452, doi. 10.1093/neuonc/noaa064
    By:
    • Lim, Eun-Jung;
    • Kim, Seungmo;
    • Oh, Yoonjee;
    • Suh, Yongjoon;
    • Kaushik, Neha;
    • Lee, Ji-Hyun;
    • Lee, Hae-June;
    • Kim, Min-Jung;
    • Park, Myung-Jin;
    • Kim, Rae-Kwon;
    • Cha, Junghwa;
    • Kim, Se Hoon;
    • Shim, Jin-Kyoung;
    • Choi, Junjeong;
    • Chang, Jong Hee;
    • Hong, Yong Kil;
    • Huh, Yong Min;
    • Kim, Pilnam;
    • Kang, Seok-Gu;
    • Lee, Su-Jae
    Publication type:
    Article
    45

    AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 6, p. 886, doi. 10.1093/neuonc/noaa045
    By:
    • Davatzikos, Christos;
    • Barnholtz-Sloan, Jill S;
    • Bakas, Spyridon;
    • Colen, Rivka;
    • Mahajan, Abhishek;
    • Quintero, Carmen Balaña;
    • Font, Jaume Capellades;
    • Puig, Josep;
    • Jain, Rajan;
    • Sloan, Andrew E;
    • Badve, Chaitra;
    • Marcus, Daniel S;
    • Choi, Yoon Seong;
    • Lee, Seung-Koo;
    • Chang, Jong Hee;
    • Poisson, Laila M;
    • Griffith, Brent;
    • Dicker, Adam P;
    • Flanders, Adam E;
    • Booth, Thomas C
    Publication type:
    Article
    46
    47
    48
    49
    50